HAT protocol
chemotherapy protocol consisting of hypoxanthine, thymidine, and an antifolate such as aminopterin; hypoxanthine and thymidine protect non-mutating cells from antifolate agent (e.g. aminopterin); mutant cells unable to utilize hypoxanthine; used as antineoplastic agent and culture media supplement
Also Known As:
HAT culture media
Networked: 1
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Experts
| 1. | Edathadathil, Fabia:
1 article
(08/2020)
|
| 2. | Greeshma, C R:
1 article
(08/2020)
|
| 3. | Menon, Anup:
1 article
(08/2020)
|
| 4. | Menon, Veena:
1 article
(08/2020)
|
| 5. | Menon, Vidya:
1 article
(08/2020)
|
| 6. | Mohamed, Zubair U:
1 article
(08/2020)
|
| 7. | Moni, Merlin:
1 article
(08/2020)
|
| 8. | Nair, Sabarish:
1 article
(08/2020)
|
| 9. | Prasanna, Preetha:
1 article
(08/2020)
|
| 10. | Prasannan, Pratibha:
1 article
(08/2020)
|